What We Know (and Don’t Know) About Global Vaccine Manufacturing Capacity

Global vaccine manufacturing capacity remains poorly defined, inconsistently measured, and insufficiently understood—limitations that undermined the COVID-19 response and, without progress, will constrain responses to future pandemics too. This paper synthesises evidence from 17 major studies and five stakeholder consultations to map how capacity is currently assessed, what these approaches capture, and where critical blind spots persist.Read More